GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
Jiff is a venture-backed, Mountain View-based technology company that is reinventing healthcare, one employee at a time. It builds customized mobile and web experiences that connect company benefits and incentives design to healthy employee behaviors using the wearables and apps that they all know and love. The company was founded in 2010 and is headquartered in Mountain View, California.
Solstice Biologics is a biotech company that provides solutions for targeting and delivering nucleic acid therapeutics. The Company specializes in the development of small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics. It was established in 2012 and is based in San Francisco, California.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Jiff is a venture-backed, Mountain View-based technology company that is reinventing healthcare, one employee at a time. It builds customized mobile and web experiences that connect company benefits and incentives design to healthy employee behaviors using the wearables and apps that they all know and love. The company was founded in 2010 and is headquartered in Mountain View, California.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Butterfly has created the world's first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world.
Jiff is a venture-backed, Mountain View-based technology company that is reinventing healthcare, one employee at a time. It builds customized mobile and web experiences that connect company benefits and incentives design to healthy employee behaviors using the wearables and apps that they all know and love. The company was founded in 2010 and is headquartered in Mountain View, California.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Smaato provides an omnichannel ad server and monetization solution with controls to make monetization simple. They connect quality publishers with premium marketers to engage audiences around the world and on every device. Publishers can bring their first-party data and manage all inventory in one place.
Sonetik offers preset hearing aids. These are set according to the most common forms of hearing loss. If it is established in their hearing test that your hearing loss falls within one of the most commonly occurring patterns of hearing loss, the software can identify for the Sonetik specialist which hearing aid matches this pattern of hearing loss. In the case of common hearing losses, further adjustments to the hearing aid are not essential. That way, you have virtually the same effect as with a hearing aid individually set by an audiologist but at a third to a fifth of the price.
Invincea is the leader in advanced endpoint threat protection, protecting more than 25,000 customers and 3 million active users. The company provides the most comprehensive solution to contain, identify, and control the advanced attacks that evade legacy security controls. Invincea protects enterprises against targeted threats, including spear-phishing and Web drive-by attacks that exploit Java, Flash, and other applications. Combining the visibility and control of an endpoint solution with the intelligence of cloud analysis, Invincea offers the only market-deployed solution that defends against 0-day exploits, file-less malware, and previously unknown malware. The company has been in market with its award-winning technology since 2009. In 2011, Invincea was recognized as "Most Innovative Company of the Year" at RSA Conference, and since then the company has won numerous awards for its technology and business. Invincea maintains an OEM agreement with Dell to ship a customized version of Invincea's award-winning endpoint security solution, under the Dell Data Protection | Protected Workspace brand. This offering ships on Dell's entire line of commercial PCs and tablets, comprising 20 million devices per year. The company, which was founded by Dr. Anup Ghosh to address the rapidly increasing security threat from nation states, cyber criminals, and rogue actors, has commercialized technology originally built under DARPA funding. The company is venture capital-backed and based in Fairfax, VA. For more information, visit https://www.invincea.com.
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
Atlantium Technologies Ltd. was established in 2003 to provide the world with safe and sustainable water treatment solutions. The company's team of scientists and engineers designed an innovative solution based on UV (ultra violet) disinfection, fiber-optics and hydraulics. It takes water safety to levels never before achieved with other UV systems or without chemicals, and provides industry and municipalities with a sustainable, measurable option. Today Atlantium is a fast-growing private company whose UV systems are field-proven globally with Fortune-500 companies among its loyal customers. Customer service centers are strategically placed to provide immediate, on-going support.
Solstice Biologics is a biotech company that provides solutions for targeting and delivering nucleic acid therapeutics. The Company specializes in the development of small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics. It was established in 2012 and is based in San Francisco, California.
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.
Private Equity Round in 2012
Solstice Biologics is a biotech company that provides solutions for targeting and delivering nucleic acid therapeutics. The Company specializes in the development of small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics. It was established in 2012 and is based in San Francisco, California.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Private Equity Round in 2012
Nanosolar prints solar cells and assembles panels to enable the most cost-efficient solar electricity. Nanosolars proprietary approach to printing CIGS (Copper, Indium, Gallium, Selenium) and nanoparticle inks using an annealing process minimizes the use of expensive, high vacuum deposition manufacturing equipment. This allows the Company to utilize equipment from the industrial printing and roll-to-roll manufacturing industries to produce solar-electric foil at high speeds, bringing the economics of printing to the world of solar PV semiconductor manufacturing.
Jiff is a venture-backed, Mountain View-based technology company that is reinventing healthcare, one employee at a time. It builds customized mobile and web experiences that connect company benefits and incentives design to healthy employee behaviors using the wearables and apps that they all know and love. The company was founded in 2010 and is headquartered in Mountain View, California.
GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.
SynapSense provides complete wireless instrumentation solutions that offer energy efficiency and carbon footprint reduction for the world's leading data centers and enterprises.
Smaato provides an omnichannel ad server and monetization solution with controls to make monetization simple. They connect quality publishers with premium marketers to engage audiences around the world and on every device. Publishers can bring their first-party data and manage all inventory in one place.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Smaato provides an omnichannel ad server and monetization solution with controls to make monetization simple. They connect quality publishers with premium marketers to engage audiences around the world and on every device. Publishers can bring their first-party data and manage all inventory in one place.
Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.
Founded in 2007, Livescribe has developed a breakthrough low-cost mobile computing platform which includes the award-winning Pulse smartpen, dot paper, smartpen applicaÂtions, Livescribe Desktop software, Livescribe Online Community, and development tools. Since its launch in April 2008, the Pulse smartpen has won multiple awards, including Popular Science’s Best of What’s New 2008, Popular Mechanic’s 2008 Breakthrough Award, and MacWorld’s Best of Show in 2009. In addition to DBL Investors, investors include VantagePoint Venture Partners and Aeris Capital.
Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Mode Media, a top 10 U.S. media property with 136 million unique users a month, was founded in Silicon Valley in 2004 with a simple, yet powerful idea—to help people discover relevant content by combining the power of human curation of premium content with technology that distributes the right content to the right people at the right time. Today, Mode Media is building the largest independent premium video and content platform for creators powered by distribution and streaming technology that delivers targeted native videos, content and branded entertainment at scale in real-time. Mode.com is an owned & operated social networking platform where creators can upload videos and build content stories. Content on Mode is curated by professional editors and distributed in user feeds—personalized by the Mode content algorithm technology. Since launch six months ago, Mode has grown from zero to 31 million unique monthly users, and crossed over 1 billion streamed video views.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Smaato provides an omnichannel ad server and monetization solution with controls to make monetization simple. They connect quality publishers with premium marketers to engage audiences around the world and on every device. Publishers can bring their first-party data and manage all inventory in one place.
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.
Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.
Conformis, Inc. is a medical technology company based in Billerica, Massachusetts, specializing in the development, manufacturing, and sale of personalized joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, Conformis creates individually sized and shaped implants tailored to fit each patient's unique anatomy. The company's product offerings include various knee replacement systems, such as iTotal CR, iTotal PS, iDuo, and iUni, as well as the Conformis Hip System and customized single-use instrumentation known as iJigs. Conformis markets its products primarily to hospitals and ambulatory surgical centers through a combination of its sales force, independent representatives, and distributors in multiple countries, including the United States and several European and Asian markets. The company emphasizes superior clinical outcomes and patient satisfaction compared to traditional off-the-shelf implants.
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which it refers to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers.
mobileo was founded with the aim of "distributing relevant content on the mobile Internet". The company was based in Hamburg (Germany) , and founded by Freddie Geier, former head of Apple Germany. As a main line for its development, mobileo wanted to enable a channel of distribution for content providers on the mobile internet, focusing around a core element, the location. In particular mobileo was very keen on providing a solution for the publishing industry in regards to the challenge of mobility, as well as on allowing the end user to contribute through the sharing of her/his favorite locations. A complete ecosystem was developed consisting of import (and normalization) components, a storage system, a server component, and mobile clients. All along this processing chain, usage was made of an internally developed technology, enabling the expression of relevance (where, when, what) for the content aggregation. This ecosystem was the foundation for both products for external customers, as well as for an own consumer product, GRYD. On the day of the launch of their consumer platform, GRYD, mobileo had to file bankruptcy due to the reason that the investor didn't fulfill is obligations.
Smaato provides an omnichannel ad server and monetization solution with controls to make monetization simple. They connect quality publishers with premium marketers to engage audiences around the world and on every device. Publishers can bring their first-party data and manage all inventory in one place.